Effect of vitamin D supplementation on metabolic syndrome in elderlies
- Conditions
- Metabolic syndrome (diabetes, obesity, blood pressure and hyperlipidemia).Metabolic disorders and nutritionalE10, E11,
- Registration Number
- IRCT2016121831449N1
- Lead Sponsor
- Ministry of Health, Nutrition Deprtment
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Food insecure, waist Circumference>90 cm, body mass index =30 kg/m2, fasting blood sugar>100 mg/dl, high blood pressure (systolic >135 mmHg and diastolic >85 mmHg) and dyslipidaemia (Low density lipoprotein= 240 mg/dl, high density lipoprotein<40 mg/dl, total cholesterol= 160 mg/dl, triglyceride = 200 mg/dl), serum 25(OH) D level <30 ng/ml, no use of vitamin D supplementation before 60 days.
Exclusion criteria: An inability or unwillingness to participate, those who are already taking any type of vitamin D supplements, Individuals with a history of allergy, those subjects with serious medical condition such as cancer, heart attack, stroke, and etc., illness that required corticosteroids or insulin, drugs are known to influence vitamin D level, steroids, anti-acids, oestrogen, people with conditions that contradict vitamin D supplementation, for example, a history of hypocalcaemia, hepatic disease or renal stones, sarcoidosis, or malignancy.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 25(OH)D. Timepoint: 8 weeks. Method of measurement: blood taking (before intervention and after intervention, 2 months later).
- Secondary Outcome Measures
Name Time Method Fasting Blood Pressure (FBS). Timepoint: 8 weeks. Method of measurement: blood taking before and after intervention (2months).;Antropometrics indicators. Timepoint: 8 weeks. Method of measurement: measuring height and weight before and after intervention (2months).;Blood Pressure. Timepoint: 8 weeks. Method of measurement: measure before and after intervention (2months).;Hyperlipidemia. Timepoint: 8 weeks. Method of measurement: blood taking before and after intervention (2months).